A5033054445- Global Maternal and Child Health
- Emergency and Acute Care Studies
- Substance Abuse Treatment and Outcomes
- Homelessness and Social Issues
- Maternal and fetal healthcare
- Health Policy Implementation Science
- Health disparities and outcomes
- Trauma and Emergency Care Studies
- Maternal and Perinatal Health Interventions
- Healthcare cost, quality, practices
- Employment and Welfare Studies
- Pelvic and Acetabular Injuries
- Pharmaceutical Practices and Patient Outcomes
- Neonatal Respiratory Health Research
- Alcohol Consumption and Health Effects
- Healthcare innovation and challenges
- Primary Care and Health Outcomes
- Child and Adolescent Health
- Alcoholism and Thiamine Deficiency
- Health Promotion and Cardiovascular Prevention
- Surgical site infection prevention
- Poisoning and overdose treatments
- Interprofessional Education and Collaboration
- Mental Health and Patient Involvement
- Global Public Health Policies and Epidemiology
North Bristol NHS Trust
2021
AIR Worldwide (United Kingdom)
2020
International Trachoma Initiative
2020
Central and North West London NHS Foundation Trust
2008-2019
King's College London
2019
University of Zimbabwe
2019
Government of India
2019
Health and Human Development (2HD) Research Network
2019
Jawaharlal Nehru Medical College
2019
North York General Hospital
2015
In 2015, an estimated 303 000 women died in pregnancy and childbirth. Obstetric haemorrhage, sepsis, hypertensive disorders of account for more than 50% maternal deaths worldwide. There are effective treatments these complications, but they require early detection by measurement vital signs timely administration to save lives. The primary aim this trial was determine whether implementation the CRADLE Vital Sign Alert education package into community facility maternity care low-resource...
The CRADLE-3 trial is a stepped-wedge randomised controlled aiming to reduce maternal mortality and morbidity by implementing novel vital sign device (CRADLE Vital Sign Alert) training package into routine maternity care in 10 low-income sites. MRC Guidance on complex interventions proposes that implementation strategies be shaped early phase piloting development work. We present the findings of three-month mixed-methodology feasibility study for this trial, describe how was informed...
To clarify the relationship between presenting clinical condition and blood alcohol concentration (BAC) among adult patients admitted to a resuscitation room (RR) of an emergency department (ED) in order help guide practice.Single-site prospective cohort study all RR inner-city hospital over one-year period. The sample comprised those aged 16 years from whom was taken, with BAC (results not known ED staff), pathology by International Classification Diseases (ICD) version 10 coding, injury...
Obstetric haemorrhage, sepsis and pregnancy hypertension account for more than 50% of maternal deaths worldwide. Early detection effective management these conditions relies on vital signs. The Microlife® CRADLE Vital Sign Alert (VSA) is an easy-to-use, accurate device that measures blood pressure pulse. It incorporates a traffic-light early warning system alerts all levels healthcare provider to the need escalation care in women with obstetric or hypertension, thereby aiding recognition...
The aim of this article is to describe the incidence and characteristics pregnancy-related death in low- middle-resource settings, relation availability key obstetric resources.This a secondary analysis stepped-wedge cluster randomised controlled trial.This trial was undertaken at ten sites across eight middle-income countries sub-Saharan Africa, India Haiti.Institutional-level consent obtained all women presenting for maternity care were eligible inclusion.Pregnancy-related deaths collected...
Interventions aimed at reducing maternal mortality are increasingly complex. Understanding how complex interventions delivered, to whom, and they work is key in ensuring their rapid scale-up. We delivered a vital signs triage intervention into routine maternity care eight low- middle-income countries with the aim of composite outcome morbidity mortality. This was pragmatic, hybrid effectiveness-implementation stepped-wedge randomised controlled trial. In this study, we present results...
<h3>Introduction</h3> Faecal calprotectin (FCP) is recommended in UK NICE guidance as a tool distinguishing inflammatory bowel disease (IBD) from Irritable Bowel Syndrome adults. Its utility for the same purpose children poorly understood and there has been concern our hospital that high rate of testing uncertainty test interpretation may be driving an increase avoidable referrals primary care. We sought to determine whether this assessment was supported by local data ascertain paediatric...